Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung
about
Using the Ferret as an Animal Model for Investigating Influenza Antiviral EffectivenessDBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation.Predicting chronic obstructive pulmonary disease hospitalizations based on concurrent influenza activityAssessment of Mexican Arnica (Heterotheca inuloides Cass) and Rosemary (Rosmarinus officinalis) Extracts on Dopamine and Selected Biomarkers of Oxidative Stress in Stomach and Brain of Salmonella typhimurium Infected rats.The mechanisms of delayed onset type adverse reactions to oseltamivir.The Effect of Oseltamivir on the Disease Progression of Lethal Influenza A Virus Infection: Plasma Cytokine and miRNA Responses in a Mouse ModelAntiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) virus and its inhibition of neuraminidase.Combinations of 1,8-cineol and oseltamivir for the treatment of influenza virus A (H3N2) infection in mice.The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases.Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.
P2860
Q27000668-951F3D2B-0CDD-4628-B47C-9995C7B86709Q30357472-5A0E0DCC-8CC3-4D19-BDAD-F34AEF43CDABQ30432654-A931FCA1-D4AB-45B5-AB8A-5CCEFF298A0CQ33647260-3CDEEEFB-F83D-44A7-A656-0B6EC74A72C7Q34677448-B4012D54-8243-4D84-8171-2F39F8113270Q36775625-96C29E3B-770C-49A9-A186-E9214269405CQ37743174-07E4B0CE-3753-447D-9F73-B315DAC71144Q39102455-9C0B1649-1D7D-4063-B294-FDD58B88F3DEQ40089465-61119E53-43A6-415F-B371-C4965817B0C5Q40112217-D92B6847-D8EA-4686-8026-3EC60D40E322Q40576505-63C7E127-E97C-4FC9-9908-DEF24FA3D119
P2860
Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oseltamivir treatment of mice ...... okine inflammation in the lung
@en
Oseltamivir treatment of mice ...... kine inflammation in the lung.
@nl
type
label
Oseltamivir treatment of mice ...... okine inflammation in the lung
@en
Oseltamivir treatment of mice ...... kine inflammation in the lung.
@nl
prefLabel
Oseltamivir treatment of mice ...... okine inflammation in the lung
@en
Oseltamivir treatment of mice ...... kine inflammation in the lung.
@nl
P2093
P2860
P1476
Oseltamivir treatment of mice ...... okine inflammation in the lung
@en
P2093
Gary P Anderson
Jessica E Jones
Rosa C Gualano
Zi Xin Wong
P2860
P304
P356
10.1111/J.1750-2659.2011.00235.X
P577
2011-03-31T00:00:00Z